NASDAQ$PETS

PetMed Express · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Announced financial results for the third quarter ended December 31, 2022.

PetMed Express reported a decrease in net sales by 3.0% compared to the same quarter last year, but saw a 9% increase in new customers, marking the first customer increase in 2.5 years. The company experienced a net loss of $19.0 thousand, compared to a net income of $4.3 million in the prior year quarter. Adjusted EBITDA decreased by 64%.

  • Net sales decreased by 3.0% to $58.9 million compared to the third quarter of the prior year.
  • New customers increased 9% year over year, representing the first customer increase in 2 1/2 years.
  • Net loss was $19.0 thousand, or $(0.00) diluted earnings per share, compared to net income of $4.3 million, or $0.21 diluted earnings per share, for the prior year quarter.
  • Adjusted EBITDA was $2.7 million, a decrease of 64% compared to $7.6 million for the quarter ended December 31, 2021.

Headline financials

Total Revenue

$58.9M

Previous: $60.7M-3.0%
EPS (adj)

$0.02

Previous: $0.21-90.5%
Capital Expenditures

-$3.33M

Previous: -$1.27M-163.0%
Free Cash Flow

$14.8M

Previous: $8.52M+73.2%
Net Income

-$19K

Previous: $4.26M-100.4%
Operating Income

-$769K

Previous: $5.15M-114.9%
Gross Profit

$15.2M

Previous: $17.7M-14.0%
Cash & Equivalents

$102M

Previous: $109M-6.0%
Total Assets

$165M

Previous: $168M-2.0%
Stock-Based Comp

$1.77M

Previous: $1.44M+22.9%

Revenue & EPS history

PetMed Express · Revenue · Quarterly

$58.9M

Q3 2023-3%vs Q3 2022
Beat estimate in 3 of 14 quarters(21%)
ActualEstimate

Forward guidance

The company expects to complete the evaluation of potential for further sales tax contingencies in the quarter ending March 31, 2023, the results of which could have a material effect on the results of operations.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-0.0%

Avg return

Earnings day

-1.6%

Avg return

5 days after

-0.4%

Avg return

30 days after

42%

27 / 65 earnings

Positive

+40.8%

Q2 2020

Best reaction

-26.4%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-16.4%-21.1%
Q3 2026-3.6%-8.7%-15.5%
Q4 2025+0.0%-4.9%-6.6%
Q2 2026-1.4%-2.7%-8.2%
Q1 2026-1.1%-1.4%-6.9%
Q3 2025-14.8%-20.1%-22.7%
Q2 2025+34.5%+27.2%+35.0%
Q1 2025-11.0%-13.0%-4.5%
Q4 2024-0.7%-1.7%-7.4%
Q3 2024+0.2%-1.2%+8.9%
Q2 2024-26.4%-23.0%-22.6%
Q1 2024-2.8%-6.4%-20.0%
Q4 2023+6.7%+1.0%-6.6%
Q3 2023-11.1%-13.3%-19.6%
Q2 2023-10.5%-4.7%-15.5%
Q1 2023+4.3%+4.2%+0.9%
Q4 2022+6.9%+2.0%+3.0%
Q3 2022+7.2%+7.7%+3.4%
Q2 2022+5.1%+5.1%+5.2%
Q1 2022+7.1%+13.0%+3.2%
Q4 2021+2.8%+0.5%+56.5%
Q3 2021-14.3%-11.1%+3.2%
Q2 2021-2.2%-3.5%-1.9%
Q1 2021-16.0%-23.8%-17.4%
Q4 2020+3.6%-4.0%-7.5%
Q3 2020-11.0%-11.2%+4.0%
Q2 2020+40.8%+32.8%+21.7%
Q1 2020+2.5%-1.5%+5.1%
Q4 2019-9.0%-9.7%-18.9%
Q3 2019-6.2%-3.4%-3.1%
Q2 2019+2.6%+1.1%-9.7%
Q1 2019-13.0%-11.8%-6.4%
Q4 2018-0.9%+1.4%+15.1%
Q3 2018-4.8%-10.2%-12.0%
Q2 2018+4.4%-5.0%+9.0%
Q1 2018+18.6%+19.3%-10.7%
Q4 2017+34.7%+41.2%+48.4%
Q3 2017-5.1%-5.4%-3.6%
Q2 2017-3.2%-4.0%+6.6%
Q1 2017+6.0%+5.8%+3.3%
Q4 2016+2.9%
Q3 2016-4.8%
Q2 2016+2.1%
Q1 2016+0.5%
Q4 2015+2.6%
Q3 2015+14.3%
Q2 2015-3.7%
Q1 2015+5.0%
Q4 2014+1.6%
Q3 2014-12.0%
Q2 2014-10.3%
Q1 2014+12.7%
Q4 2013-0.5%
Q3 2013+7.0%
Q2 2013+6.9%
Q1 2013-16.3%
Q4 2012-5.4%
Q4 2010-5.4%
Q3 2011-0.2%
Q3 2012-0.2%
Q2 2012-0.8%
Q2 2011-0.8%
Q1 2012-0.1%
Q1 2011-0.1%
Q4 2011-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro